| Type |
Details |
Score |
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1679523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_17 |
|
| Specimen Label: |
euxassay_007703_17 |
| Detected: |
true |
| Specimen Num: |
17 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_09 |
|
| Specimen Label: |
euxassay_007703_09 |
| Detected: |
true |
| Specimen Num: |
9 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_10 |
|
| Specimen Label: |
euxassay_007703_10 |
| Detected: |
true |
| Specimen Num: |
10 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_11 |
|
| Specimen Label: |
euxassay_007703_11 |
| Detected: |
true |
| Specimen Num: |
11 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_12 |
|
| Specimen Label: |
euxassay_007703_12 |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_13 |
|
| Specimen Label: |
euxassay_007703_13 |
| Detected: |
true |
| Specimen Num: |
13 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_14 |
|
| Specimen Label: |
euxassay_007703_14 |
| Detected: |
true |
| Specimen Num: |
14 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_15 |
|
| Specimen Label: |
euxassay_007703_15 |
| Detected: |
true |
| Specimen Num: |
15 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_16 |
|
| Specimen Label: |
euxassay_007703_16 |
| Detected: |
true |
| Specimen Num: |
16 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_17 |
|
| Specimen Label: |
euxassay_007703_17 |
| Detected: |
true |
| Specimen Num: |
17 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1757723 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_18 |
|
| Specimen Label: |
euxassay_007703_18 |
| Detected: |
true |
| Specimen Num: |
18 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1679823 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_06 |
|
| Specimen Label: |
euxassay_007703_06 |
| Detected: |
true |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1679823 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_16 |
|
| Specimen Label: |
euxassay_007703_16 |
| Detected: |
true |
| Specimen Num: |
16 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_01 |
|
| Specimen Label: |
euxassay_007703_01 |
| Detected: |
true |
| Specimen Num: |
1 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_02 |
|
| Specimen Label: |
euxassay_007703_02 |
| Detected: |
true |
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_03 |
|
| Specimen Label: |
euxassay_007703_03 |
| Detected: |
true |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_04 |
|
| Specimen Label: |
euxassay_007703_04 |
| Detected: |
true |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_05 |
|
| Specimen Label: |
euxassay_007703_05 |
| Detected: |
true |
| Specimen Num: |
5 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_06 |
|
| Specimen Label: |
euxassay_007703_06 |
| Detected: |
true |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_07 |
|
| Specimen Label: |
euxassay_007703_07 |
| Detected: |
true |
| Specimen Num: |
7 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_08 |
|
| Specimen Label: |
euxassay_007703_08 |
| Detected: |
true |
| Specimen Num: |
8 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_09 |
|
| Specimen Label: |
euxassay_007703_09 |
| Detected: |
true |
| Specimen Num: |
9 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_10 |
|
| Specimen Label: |
euxassay_007703_10 |
| Detected: |
true |
| Specimen Num: |
10 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_11 |
|
| Specimen Label: |
euxassay_007703_11 |
| Detected: |
true |
| Specimen Num: |
11 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_12 |
|
| Specimen Label: |
euxassay_007703_12 |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_13 |
|
| Specimen Label: |
euxassay_007703_13 |
| Detected: |
true |
| Specimen Num: |
13 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_14 |
|
| Specimen Label: |
euxassay_007703_14 |
| Detected: |
true |
| Specimen Num: |
14 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_15 |
|
| Specimen Label: |
euxassay_007703_15 |
| Detected: |
true |
| Specimen Num: |
15 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_16 |
|
| Specimen Label: |
euxassay_007703_16 |
| Detected: |
true |
| Specimen Num: |
16 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_17 |
|
| Specimen Label: |
euxassay_007703_17 |
| Detected: |
true |
| Specimen Num: |
17 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_18 |
|
| Specimen Label: |
euxassay_007703_18 |
| Detected: |
true |
| Specimen Num: |
18 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_19 |
|
| Specimen Label: |
euxassay_007703_19 |
| Detected: |
true |
| Specimen Num: |
19 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_20 |
|
| Specimen Label: |
euxassay_007703_20 |
| Detected: |
true |
| Specimen Num: |
20 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_21 |
|
| Specimen Label: |
euxassay_007703_21 |
| Detected: |
true |
| Specimen Num: |
21 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_22 |
|
| Specimen Label: |
euxassay_007703_22 |
| Detected: |
true |
| Specimen Num: |
22 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_23 |
|
| Specimen Label: |
euxassay_007703_23 |
| Detected: |
true |
| Specimen Num: |
23 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4423770 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4825053 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_007703_24 |
|
| Specimen Label: |
euxassay_007703_24 |
| Detected: |
true |
| Specimen Num: |
24 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang CF |
| Year: |
2012 |
| Journal: |
Mol Cell Biol |
| Title: |
Calpain 2 activated through N-methyl-D-aspartic acid receptor signaling cleaves CPEB3 and abrogates CPEB3-repressed translation in neurons. |
| Volume: |
32 |
| Issue: |
16 |
| Pages: |
3321-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Branca D |
| Year: |
2004 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Calpain-related diseases. |
| Volume: |
322 |
| Issue: |
4 |
| Pages: |
1098-104 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bate N |
| Year: |
2012 |
| Journal: |
PLoS One |
| Title: |
Talin contains a C-terminal calpain2 cleavage site important in focal adhesion dynamics. |
| Volume: |
7 |
| Issue: |
4 |
| Pages: |
e34461 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Saraiva N |
| Year: |
2013 |
| Journal: |
J Cell Biol |
| Title: |
hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. |
| Volume: |
202 |
| Issue: |
4 |
| Pages: |
699-713 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Magnaghi-Jaulin L |
| Year: |
2010 |
| Journal: |
Chromosoma |
| Title: |
Calpain 2 is required for sister chromatid cohesion. |
| Volume: |
119 |
| Issue: |
3 |
| Pages: |
267-74 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu Y |
| Year: |
2016 |
| Journal: |
Neuropharmacology |
| Title: |
A calpain-2 selective inhibitor enhances learning & memory by prolonging ERK activation. |
| Volume: |
105 |
|
| Pages: |
471-477 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Subramanian V |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain-1 deficient mice. |
| Volume: |
8 |
| Issue: |
8 |
| Pages: |
e72214 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Storr SJ |
| Year: |
2012 |
| Journal: |
J Cell Mol Med |
| Title: |
Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer. |
| Volume: |
16 |
| Issue: |
10 |
| Pages: |
2422-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shih M |
| Year: |
2006 |
| Journal: |
Exp Eye Res |
| Title: |
Biochemical properties of lens-specific calpain Lp85. |
| Volume: |
82 |
| Issue: |
1 |
| Pages: |
146-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ho WC |
| Year: |
2012 |
| Journal: |
J Biol Chem |
| Title: |
Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma. |
| Volume: |
287 |
| Issue: |
19 |
| Pages: |
15458-65 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the Ca2 -binding penta-EF-hand (PEF) domain found in CAPN2 (also known as Calpain 2). CAPN2 is a ubiquitously expressed Ca2 -dependent intracellular cysteine protease that contains a short N-terminal anchor helix, followed by a calpain cysteine protease (CysPc) domain, a C2-domain-like (C2L) domain, and a C-terminal Ca2 -binding penta-EF-hand (PEF) domain []. The catalytic subunit CAPN2 in complex with a regulatory subunit encoded by CAPNS1 forms an m-calpain heterodimer[]. CAPN2 acts as the key protease responsible for N-methyl-d-aspartic acid (NMDA)-induced cytoplasmic polyadenylation element-binding protein 3 (CPEB3) degradation in neurons []. It cleaves several components of the focal adhesion complex, such as FAK and talin, triggering disassembly of the complex at the rear of the cell []. The stimulation of CAPN2 activity is required for Golgi antiapoptotic proteins (GAAPs) to promote cleavage of FA kinase (FAK), cell spreading, and enhanced migration. calpain 2 is also involved in the onset of glial differentiation []. It regulates proliferation, survival, migration, and tumorigenesis of breast cancer cells through a PP2A-Akt-FoxO-p27(Kip1) signalling cascade []. Its expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer []. Moreover, CAPN2 may play a role in fundamental mitotic functions, such as the maintenance of sister chromatid cohesion []. The activation of CAPN2 plays an essential role in hippocampal synaptic plasticity and in learning and memory []. In the eye, CAPN2, together with a lens-specific variant of CAPN3, is responsible for proteolytic cleavages of alpha and beta-crystallin. Overactivated alpha and beta-crystallin can lead to cataract formation []. Sometimes, CAPN2 compensates for loss of CAPN1, and both calpain isoforms are involved in AngII-induced aortic aneurysm formation []. The main phosphorylation sites in m-calpain are Ser50 and Ser369/Thr370. |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
622
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
645
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1130
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
666
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
501
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
586
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
501
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
603
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
449
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
394
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
605
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
564
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
299
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
595
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yaremchuk A |
| Year: |
2001 |
| Journal: |
J Mol Biol |
| Title: |
A succession of substrate induced conformational changes ensures the amino acid specificity of Thermus thermophilus prolyl-tRNA synthetase: comparison with histidyl-tRNA synthetase. |
| Volume: |
309 |
| Issue: |
4 |
| Pages: |
989-1002 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang H |
| Year: |
2016 |
| Journal: |
J Mol Biol |
| Title: |
Structure of Human GIVD Cytosolic Phospholipase A2 Reveals Insights into Substrate Recognition. |
| Volume: |
428 |
| Issue: |
13 |
| Pages: |
2769-79 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nygren PJ |
| Year: |
2016 |
| Journal: |
Biochem Soc Trans |
| Title: |
Regulation of the phosphatase PP2B by protein-protein interactions. |
| Volume: |
44 |
| Issue: |
5 |
| Pages: |
1313-1319 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Colbran RJ |
| Year: |
2004 |
| Journal: |
J Neurosci |
| Title: |
Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity. |
| Volume: |
24 |
| Issue: |
39 |
| Pages: |
8404-9 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
PP2B (calcineurin) is a unique serine/threonine protein phosphatase in its regulation by a second messenger (calcium acting via calmodulin) [, ]. PP2B is involved in many biological processes including immune responses, the second messenger cAMP pathway, sodium/potassium ion transport in the nephron, cell cycle progression in lower eukaryotes, cardiac hypertrophy and memory formation. PP2B is highly conserved from yeast to humans, but is absent from plants. PP2B is a heterodimer consisting of a catalytic subunit (CnA) and a regulatory subunit (CnB); CnB contains four Ca2 binding motifs referred to as EF hands []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This domain of approximately 100 residues is conserved from plants to humans. It is an anticodon-binding domain of a prolyl-tRNA synthetase []. It is found in Lms12 and homologues. Lsm12 is a putative RNA-binding and regulation protein that might be involved in mRNA degradation or tRNA splicing []. Recently, it was demonstrated that it binds nicotinic acid adenine dinucleotide phosphate (NAADP) that confers NAADP sensitivity to the two pore channel complex (TPCs) by acting as TPC accessory protein necessary for NAADP-evoked Ca2 release []. Therefore, further studies of the potential crosstalk between NAADP signaling and RNA regulation are required. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
RGS14 is a regulator of G protein signaling (RGS) protein. It regulates G protein nucleotide exchange and hydrolysis by acting as a GTPase-activating protein (GAP) through its RGS domain, and as a guanine nucleotide dissociation inhibitor (GDI) through its GoLoco motif [, ]. Both domains of RGS14 target members of the Gialpha subclass []. It is a microtubule-associated protein that may modulate microtubule dynamics and spindle formation []and play an essential role during mammalian cell division []. RGS14 regulates the activation of alphaMbeta2 integrin during phagocytosis []. It is a key regulator of signalling pathways linking synaptic plasticity in CA2 pyramidal neurons to hippocampal-based learning and memory []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
The troponin (Tn) complex regulates calcium-induced muscle contraction. Tn contains three subunits, Ca2 binding (TnC), inhibitory (TnI), and tropomyosin binding (TnT), which is required for Ca(2)-mediated activation of actomyosin ATPase activity [, ]. Three different troponin T genes that encode tissue-specific isoforms of subunit T have been found in mammals and birds, encoding cardiac (TNNT2), slow (TNNT1), and fast (TNNT3) skeletal muscle TnT isoforms [, , , ].This entry represents the fast (TNNT3) skeletal muscle TnT isoform. Defects in TNNT3 are a cause of distal arthrogryposis type 2B (DA2B); also known as arthrogryposis multiplex congenita, distal, type 2B (AMCD2B) []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Cytosolic phospholipases A2 (cPLA2s) consist of a family of calcium-sensitive enzymes that function to generate lipid second messengers through hydrolysis of membrane-associated glycerophospholipids. In humans, the cPLA2 family contains six isoforms. Structural information of full length cPLA2alpha apo form, shows that it is composed of two domains; an N-terminal Ca2 + binding C2 domain and a C-terminal alpha/beta hydrolase core. This entry describes the N-terminal Ca2+ binding C2 domain which is composed of an eight-stranded antiparallel β-sandwich consisting of two four-stranded β-sheets. C2 domains are present in many lipid-binding proteins including Copines, CAPRI and Rabphilin-3A all of which are involved in membrane trafficking []. |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Allele |
| Name: |
deletion, Chr5, Victoria Campuzano 1; deletion, Chr 5, Victoria Campuzano 1 |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kaji K |
| Year: |
2000 |
| Journal: |
Nat Genet |
| Title: |
The gamete fusion process is defective in eggs of Cd9-deficient mice. |
| Volume: |
24 |
| Issue: |
3 |
| Pages: |
279-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Barlow GM |
| Year: |
2001 |
| Journal: |
Cytogenet Cell Genet |
| Title: |
Down syndrome cell adhesion molecule is conserved in mouse and highly expressed in the adult mouse brain. |
| Volume: |
94 |
| Issue: |
3-4 |
| Pages: |
155-62 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chand D |
| Year: |
2013 |
| Journal: |
Mol Cell Neurosci |
| Title: |
C-terminal processing of the teneurin proteins: independent actions of a teneurin C-terminal associated peptide in hippocampal cells. |
| Volume: |
52 |
|
| Pages: |
38-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nullmeier S |
| Year: |
2011 |
| Journal: |
Eur J Neurosci |
| Title: |
Region-specific alteration of GABAergic markers in the brain of heterozygous reeler mice. |
| Volume: |
33 |
| Issue: |
4 |
| Pages: |
689-98 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Han SH |
| Year: |
2000 |
| Journal: |
Ann N Y Acad Sci |
| Title: |
Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice. |
| Volume: |
903 |
|
| Pages: |
357-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Williams Avram SK |
| Year: |
2019 |
| Journal: |
Front Behav Neurosci |
| Title: |
NMDA Receptor in Vasopressin 1b Neurons Is Not Required for Short-Term Social Memory, Object Memory or Aggression. |
| Volume: |
13 |
|
| Pages: |
218 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiang MC |
| Year: |
2018 |
| Journal: |
Behav Brain Res |
| Title: |
A role for CA3 in social recognition memory. |
| Volume: |
354 |
|
| Pages: |
22-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gottschling C |
| Year: |
2019 |
| Journal: |
Sci Rep |
| Title: |
Elimination of the four extracellular matrix molecules tenascin-C, tenascin-R, brevican and neurocan alters the ratio of excitatory and inhibitory synapses. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
13939 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nagatomo I |
| Year: |
1998 |
| Journal: |
Brain Res |
| Title: |
Influence of dietary zinc on convulsive seizures and hippocampal NADPH diaphorase-positive neurons in seizure susceptible EL mouse. |
| Volume: |
789 |
| Issue: |
2 |
| Pages: |
213-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bearzatto B |
| Year: |
2006 |
| Journal: |
FASEB J |
| Title: |
Targeted calretinin expression in granule cells of calretinin-null mice restores normal cerebellar functions. |
| Volume: |
20 |
| Issue: |
2 |
| Pages: |
380-2 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Uetani N |
| Year: |
2000 |
| Journal: |
EMBO J |
| Title: |
Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. |
| Volume: |
19 |
| Issue: |
12 |
| Pages: |
2775-85 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li Q |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Timing specific requirement of microRNA function is essential for embryonic and postnatal hippocampal development. |
| Volume: |
6 |
| Issue: |
10 |
| Pages: |
e26000 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu X |
| Year: |
2021 |
| Journal: |
Nature |
| Title: |
5-HT modulation of a medial septal circuit tunes social memory stability. |
| Volume: |
599 |
| Issue: |
7883 |
| Pages: |
96-101 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Koike M |
| Year: |
2013 |
| Journal: |
Eur J Neurosci |
| Title: |
Differences in expression patterns of cathepsin C/dipeptidyl peptidase I in normal, pathological and aged mouse central nervous system. |
| Volume: |
37 |
| Issue: |
5 |
| Pages: |
816-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bygrave AM |
| Year: |
2019 |
| Journal: |
Transl Psychiatry |
| Title: |
Hippocampal-prefrontal coherence mediates working memory and selective attention at distinct frequency bands and provides a causal link between schizophrenia and its risk gene GRIA1. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
142 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Llewellyn KJ |
| Year: |
2015 |
| Journal: |
Neurobiol Dis |
| Title: |
Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome. |
| Volume: |
76 |
|
| Pages: |
77-86 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kilonzo K |
| Year: |
2022 |
| Journal: |
Transl Psychiatry |
| Title: |
Distinct contributions of GluA1-containing AMPA receptors of different hippocampal subfields to salience processing, memory and impulse control. |
| Volume: |
12 |
| Issue: |
1 |
| Pages: |
102 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tehranian R |
| Year: |
2006 |
| Journal: |
Brain Res |
| Title: |
Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. |
| Volume: |
1101 |
| Issue: |
1 |
| Pages: |
126-35 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
DeVito LM |
| Year: |
2009 |
| Journal: |
J Neurosci |
| Title: |
Vasopressin 1b receptor knock-out impairs memory for temporal order. |
| Volume: |
29 |
| Issue: |
9 |
| Pages: |
2676-83 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Evans PR |
| Year: |
2014 |
| Journal: |
J Comp Neurol |
| Title: |
Postnatal developmental expression of regulator of G protein signaling 14 (RGS14) in the mouse brain. |
| Volume: |
522 |
| Issue: |
1 |
| Pages: |
186-203 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Samadi M |
| Year: |
2023 |
| Journal: |
Hippocampus |
| Title: |
Mechanisms of mGluR-dependent plasticity in hippocampal area CA2. |
| Volume: |
33 |
| Issue: |
6 |
| Pages: |
730-744 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
D'Hooge R |
| Year: |
2005 |
| Journal: |
J Neurosci |
| Title: |
Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis. |
| Volume: |
25 |
| Issue: |
28 |
| Pages: |
6539-49 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ikawa F |
| Year: |
2021 |
| Journal: |
Brain Res |
| Title: |
Detailed neuronal distribution of GPR3 and its co-expression with EF-hand calcium-binding proteins in the mouse central nervous system. |
| Volume: |
1750 |
|
| Pages: |
147166 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang H |
| Year: |
2010 |
| Journal: |
J Neurochem |
| Title: |
The Reck tumor suppressor protein alleviates tissue damage and promotes functional recovery after transient cerebral ischemia in mice. |
| Volume: |
115 |
| Issue: |
2 |
| Pages: |
385-98 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Purohit P |
| Year: |
2014 |
| Journal: |
PLoS One |
| Title: |
The Ca2+ sensor protein swiprosin-1/EFhd2 is present in neurites and involved in kinesin-mediated transport in neurons. |
| Volume: |
9 |
| Issue: |
8 |
| Pages: |
e103976 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Augé E |
| Year: |
2018 |
| Journal: |
Glia |
| Title: |
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease. |
| Volume: |
66 |
| Issue: |
10 |
| Pages: |
2094-2107 |
|
•
•
•
•
•
|